Yi Tao, Pharm.D. (she/her/hers)

WuXi AppTec (Shanghai) Co., Ltd., China (People's Republic)

Poster(s):

• (M1330-06-40) A Comprehensive Bioanalytical Strategy of In Vivo Studies for RNAi Therapeutics in Early Discovery
  Monday, October 23, 2023

  1:30 PM – 2:30 PM ET

• (M0930-06-41) Comparison of Branched DNA (B-DNA) and Polymerase Chain Reaction (RT-qPCR) Method Validation for the Quantification of mRNA Therapeutics in Plasma
  Monday, October 23, 2023

  9:30 AM – 10:30 AM ET

• (M1330-10-63) Effect of pH on Metabolite Profiling and Identification of GalNAc Conjugated siRNA in In Vitro Metabolic System
  Monday, October 23, 2023

  1:30 PM – 2:30 PM ET

• (T1530-10-69) Evidence-Based Strategies for the Characterization of New Chemical Entity (NCE) In Vitro CYP and Non-CYP Enzyme Reaction Phenotyping at the Development Stage
  Tuesday, October 24, 2023

  3:30 PM – 4:30 PM ET

• (T1230-10-69) Metabolite Identification of Nucleoside Analog Prodrugs in Biological Matrix by Derivatization Coupled with Radio-Detector and Mass Spectrometry
  Tuesday, October 24, 2023

  12:30 PM – 1:30 PM ET

• (T0930-06-38) Quantitative Analysis of GalNAc-siRNA Conjugates in Tissue Homogenate Using Two-Dimensional Liquid Chromatography Coupled with Tandem Mass Spectrometry
  Tuesday, October 24, 2023

  9:30 AM – 10:30 AM ET

• (T1430-06-41) Research Strategy of Chiral PROTACs in Discovery Stage Based on Analysis Platforms of UPCC-MS/MS and UPLC-MS/MS
  Tuesday, October 24, 2023

  2:30 PM – 3:30 PM ET

• (W1030-05-33) Study on the Permeability of Ophthalmic Tissues In Vitro
  Wednesday, October 25, 2023

  10:30 AM – 11:30 AM ET